Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Armònia Italy Fund II merges three firms to create high-tech manufacturing group
Armònia Italy Fund II merges three firms to create high-tech manufacturing group Armònia Italy Fund II, managed by Armònia SGR, has finalised its second investment with the acquisition of a majority stake in a newly created industrial group formed by the integration...
TPG and Aquarian in final race for $3.4bn Brighthouse Financial acquisition
TPG and Aquarian in final race for $3.4bn Brighthouse Financial acquisition Private equity heavyweight TPG and Mubadala-backed Aquarian Holdings have reached the final stage in the bidding process for Brighthouse Financial, the $3.4bn US life insurer carved out of...
EBRD, Morphosis Capital, and CEECAT exit La Cocoş as Schwarz Group acquires 70% stake
EBRD, Morphosis Capital, and CEECAT exit La Cocoş as Schwarz Group acquires 70% stake Morphosis Capital, CEECAT Capital, and the EBRD have exited Romanian discount retailer La Cocoş, selling their stakes to the Schwarz Group in a deal that sees the German retail giant...